Table of Contents
Orally Inhaled and Nasal Drug Products (OINDP) Subcommittee Report to the Advisory Committee for Pharmaceutical Sciences Rockville, Maryland November 15, 2000
Outline
Published OINDP Draft CMC Guidances (Under Revision)
Activities Since Publication of the OINDP Draft Guidances
Dose Content Uniformity
PPT Slide
Summary of Comments on Question A
PPT Slide
Summary of Comments on Question B
|
Author: CDER User
|